Literature DB >> 9151813

Expression and purification of vesicular stomatitis virus N-P complex from Escherichia coli: role in genome RNA transcription and replication in vitro.

A K Gupta1, A K Banerjee.   

Abstract

The nucleocapsid protein (N) and phosphoprotein (P) genes of vesicular stomatitis virus (VSV), Indiana serotype, were coexpressed in Escherichia coli BL21(DE3) by using the expression vector pET-3a. The coexpression resulted in the formation of N-P complex. The purified N-P complex was found to inhibit transcription in vitro mediated by viral ribonucleoprotein (RNP) complex in a dose-dependent manner. However, addition of uninfected mammalian cell extracts together with the N-P complex to the transcribing RNP resulted in the synthesis of full-length negative-strand genome RNA. These results indicate that the N-P complex regulated transcription and a cellular factor(s) in combination with the N-P complex may switch the RNA polymerase from transcription to replication mode.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151813      PMCID: PMC191641     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro.

Authors:  B P De; A K Banerjee
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

2.  Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations.

Authors:  M Schubert; G G Harmison; E Meier
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

3.  Efficient interaction of the vesicular stomatitis virus P protein with the L protein or the N protein in cells expressing the recombinant proteins.

Authors:  A M Takacs; A K Banerjee
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

4.  Synthesis in vitro of full length genomic RNA and assembly of the nucleocapsid of vesicular stomatitis virus in a coupled transcription-translation system.

Authors:  K Ghosh; H P Ghosh
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

5.  Protein kinase activity associated with immunoprecipitates of the vesicular stomatitis virus phosphoprotein NS.

Authors:  J C Bell; E G Brown; D Takayesu; L Prevec
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

6.  Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein.

Authors:  J Sprague; J H Condra; H Arnheiter; R A Lazzarini
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Preparation and analysis of the nucleocapsid proteins of vesicular stomatitis virus and sendai virus, and analysis of the sendai virus leader-NP gene region.

Authors:  B M Blumberg; C Giorgi; K Rose; D Kolakofsky
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

8.  RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.

Authors:  G W Wertz; M Levine
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

9.  N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus.

Authors:  J T Patton; N L Davis; G W Wertz
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

10.  Initiation and replication of vesicular stomatitis virus genome RNA in a cell-free system.

Authors:  R W Peluso; S A Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  14 in total

1.  A confocal and electron microscopic comparison of interferon beta-induced changes in vesicular stomatitis virus infection of neuroblastoma and nonneuronal cells.

Authors:  Paul M D'Agostino; Carol Shoshkes Reiss
Journal:  DNA Cell Biol       Date:  2010-03       Impact factor: 3.311

2.  The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C.

Authors:  A K Gupta; D Blondel; S Choudhary; A K Banerjee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Identification of a novel tripartite complex involved in replication of vesicular stomatitis virus genome RNA.

Authors:  Ashim K Gupta; Daniel Shaji; Amiya K Banerjee
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Optimal replication activity of vesicular stomatitis virus RNA polymerase requires phosphorylation of a residue(s) at carboxy-terminal domain II of its accessory subunit, phosphoprotein P.

Authors:  L N Hwang; N Englund; T Das; A K Banerjee; A K Pattnaik
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 5.  Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.

Authors:  Christian K Pfaller; Roberto Cattaneo; Matthias J Schnell
Journal:  Virology       Date:  2015-02-18       Impact factor: 3.616

6.  Study of the assembly of vesicular stomatitis virus N protein: role of the P protein.

Authors:  T J Green; S Macpherson; S Qiu; J Lebowitz; G W Wertz; M Luo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  IFN-beta-induced alteration of VSV protein phosphorylation in neuronal cells.

Authors:  Paul M D'agostino; Jessica J Amenta; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

8.  Display of disparate transcription phenotype by the phosphorylation negative P protein mutants of vesicular stomatitis virus, Indiana serotype, expressed in E. coli and eucaryotic cells.

Authors:  M Mathur; T Das; J L Chen; D Chattopadhyay; A K Banerjee
Journal:  Gene Expr       Date:  1997

9.  Specific interaction of heterogeneous nuclear ribonucleoprotein particle U with the leader RNA sequence of vesicular stomatitis virus.

Authors:  A K Gupta; J A Drazba; A K Banerjee
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Structure of the vesicular stomatitis virus N⁰-P complex.

Authors:  Cédric Leyrat; Filip Yabukarski; Nicolas Tarbouriech; Euripedes A Ribeiro; Malene Ringkjøbing Jensen; Martin Blackledge; Rob W H Ruigrok; Marc Jamin
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.